نتایج جستجو برای: carcinoma transitional cell

تعداد نتایج: 1893049  

2004
A Charlton

Background and aims: Germline mutations in the CDH-1/E-cadherin gene are, to date, the only known cause of hereditary diffuse gastric cancer (HDGC). While two recent series of prophylactic gastrectomy described microscopic foci of signet ring cell carcinoma in sample sections from 10 macroscopically normal stomachs, whole stomach phenotype has not been mapped. We aimed to describe the size and ...

Journal: :Urologia internationalis 1955
T Erdoğru I Kiliçaslan T Esen H Ander O Ziylan V Uysal

The signet ring cell carcinoma of the urinary bladder is a rare neoplasm; the 70 cases found in the literature pursued a fulminant and mostly fatal course; the neoplasms diffusely invaded the bladder wall without forming intraluminal growths and could not be controlled by segmental resection, radiotherapy and chemotherapy alone or in combination. We herewith present 2 cases of primary signet ri...

Journal: :Journal of clinical pathology 1995
M Mori K Mimori T Kamakura Y Adachi Y Ikeda K Sugimachi

AIMS Immunostaining of chromogranin identifies gastrointestinal mucosal endocrine cells. The detailed distribution and significance of chromogranin positive cells in colorectal carcinomas and in transitional mucosa remain unclear. The aim of this study was to clarify these aspects. METHODS The distribution of chromogranin positive cells was studied by immunohistochemical methods in normal epi...

Journal: :American journal of clinical pathology 2000
P Chu D A Arber

We tested 505 cases of nonhematopoietic neoplasms by immunohistochemistry using a newly characterized monoclonal antibody (clone 56C6) against the CD10 antigen. CD10 was expressed widely in neoplasms of the genitourinary tract, including 41 (89%) of 46 cases of renal cell carcinoma, 13 (54%) of 24 cases of transitional cell carcinoma, and 11 (61%) of 18 cases of prostatic adenocarcinoma. In add...

2017
W. Kerkeni Y. Ayari L. Charfi A. Bouzouita H. Ayed M. Cherif M.R. Ben Slama K. Mrad A. Derouiche M. Chebil

Cutaneous metastases from bladder malignancies are rare. We report the case of a 74 year old man who underwent cysto-prostatectomy and adjuvant chemotherapy for a pT3b N+ bladder transitional cell carcinoma. Four months later, he presented with skin disseminated pigmented lesions. Skin biopsy confirmed cutaneous metastasis from urothelial carcinoma.

2012
Michał Kupś Marcin Słojewski Oleg Oszurek Andrzej Sikorski

Etiologic factors affecting bladder tumor have been well confirmed and it is widely recognized that carcinogenic substances in urine may play an important role in a pathogenesis. Carcinoma developing in a defunctionalized bladder, although uncommon, does occur. We report a case of a transitional cell carcinoma (TCC) found in a remaining bladder of a male patient and a review of the most relevan...

Journal: :International braz j urol : official journal of the Brazilian Society of Urology 2004
Mirandolino B Mariano Marcos V Tefilli

PROPOSAL The authors present their initial experience with a selected group of patients who underwent laparoscopic partial cystectomy for treating bladder cancer. MATERIALS AND METHODS In the period from June 1997 to April 2000, 6 patients, aged between 38 and 76 years, having transitional cell carcinoma of the bladder, were identified as candidates to partial cystectomy. The procedure employ...

2008
Navér A. Sarkissian Jonathan F. Lara

We describe an unusual case of high-grade transitional cell carcinoma of the renal pelvis with sarcomatoid and squamous differentiation that presented as a left renal abscess. The patient had originally been treated for minimally invasive transitional cell carcinoma of the urinary bladder and ureteral orifices five years prior. Computerized tomography scan findings were consistent with an absce...

Journal: :Actas dermo-sifiliograficas 2013
M García Baldoví M Pérez-Crespo J Onrubia M Moragón

Transitional cell carcinoma of the bladder is an aggressive tumor with a high potential for malignant progression. Bacille Calmette-Guérin (BCG) has been used to treat malignant diseases for more than 20 years, and bladder cancer has been treated with it longer, since 1976. BCG is an attenuated strain of Mycobacterium bovis; instilled in solution to treat bladder cancer, it delays recurrence an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید